single chain antibodies against gp55 of human cytomegalovirus (hcmv) for prophylaxis and treatment of hcmv infections

نویسندگان

bahareh moazen student research committee, shiraz university of medical sciences, shiraz, ir iran

elahe ebrahimi department of immunology, recombinant antibody laboratory, shiraz university of medical sciences, shiraz, ir iran

foroogh nejatollahi shiraz hiv/aids research center, shiraz university of medical sciences, shiraz, ir iran; department of immunology, recombinant antibody laboratory, shiraz university of medical sciences, shiraz, ir iran; department of immunology, recombinant antibody laboratory, shiraz university of medical sciences, shiraz, ir iran. tel: +98-7112351575, fax: +98-7112351575

چکیده

conclusions gp55 of human cmv is considered as an important candidate for immunotherapy. in this study, we selected three specific clones against gp55. the scfvs reacted only with the corresponding peptide in a positive elisa. the scfv2 with 68.8% neutralizing effect showed the potential to be considered for prophylaxis and treatment of cmv infections, especially in solid organ transplant recipients, for whom treatment of cmv is urgently needed. the scfv2 with neutralizing effect of 68.8%, has the potential to be considered for treatment of these patients. the specific scfv1 and scfv3 with lower neutralizing effects can be used for diagnostic purposes. materials and methods single chain antibodies specific against an epitope located in the c-terminal part of gp55 were selected from a phage antibody display library. after four rounds of panning, twenty clones were amplified by the polymerase chain reaction (pcr) and fingerprinted by mvai restriction enzyme. the reactivities of the specific clones were tested by the enzyme-linked immunosorbent assay (elisa) and the neutralizing effects were evaluated by the plaque reduction assay. results fingerprinting of selected clones revealed three specific single chain antibodies (scfv1, scfv2 and scfv3) with frequencies 25%, 20 and 20%. the clones produced positive elisa with the corresponding peptide. the percentages of plaque reduction for scfv1, scfv2 and scfv3 were 23.7, 68.8 and 11.6, respectively. objectives the aim of this study was to select specific single chain antibodies against gp55 of cmv and to evaluate their neutralizing effects. in the present study, we selected specific single chain antibodies against glycoprotein 55 (gp55) of cmv for their use in treatment and diagnosis. background immunotherapy is a promising prospective new treatment for cytomegalovirus (cmv) infections. neutralizing effects have been reported using monoclonal antibodies. recombinant single chain antibodies (scfvs) due to their advantages over monoclonal antibodies are potential alternatives and provide valuable clinical agents.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

The microRNA Transcriptome of Human Cytomegalovirus (HCMV)

The purpose of the present study was to characterize the microRNA transcriptome (miRNAome) of the human cytomegalovirus (HCMV or HHV5). We used deep sequencing and real time PCR (qPCR) together with bioinformatics to analyze the pattern of small RNA expression in cells infected with low-passage isolates of HCMV as well as in plasma and amniotic fluid. We report here on the discovery of four new...

متن کامل

Circulating endothelial giant cells permissive for human cytomegalovirus (HCMV) are detected in disseminated HCMV infections with organ involvement.

Giant cells fully permissive for human cytomegalovirus (HCMV) were found to circulate, at a variable proportion, in peripheral blood of 21 out of 25 immunocompromised patients with disseminated HCMV infection. Circulating endothelial giant cells (EGC) were identified by a specific monoclonal antibody of endothelial origin and shown to express immediate-early, early, and late viral proteins. Imm...

متن کامل

Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: model of HCMV latency.

Clinical experience and laboratory data suggest that human cytomegalovirus (HCMV) is present in peripheral blood of seropositive individuals in a latent or persistent state and can be transmitted via blood products and be reactivated in seropositive immunocompromised patients. The pathophysiology of HCMV latency and the nature of HCMV interaction with hematopoietic cells remains unknown. In thi...

متن کامل

Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication.

This study examines the role of the cellular protein hDaxx in controlling human cytomegalovirus (HCMV) immediate-early (IE) gene expression and viral replication. Using permissive cell lines that either overexpress hDaxx or are depleted of hDaxx expression by the use of short hairpin RNA, we demonstrate that hDaxx functions as a repressor of HCMV IE gene expression and replication. In addition,...

متن کامل

Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts.

Human cytomegalovirus (HCMV) can infect both HCMV-naive and -experienced transplant patients. In this study, the growth rate of HCMV in HCMV-naive hosts (1.82 units/day; 95% confidence interval [CI], 1.44-2.56 units/day) was shown to be significantly faster than the growth rate of virus in HCMV-experienced hosts undergoing recurrent infection (0.61 units/day; 95% CI, 0.55-0.7 units/day; P<.0001...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
jundishapur journal of microbiology

جلد ۹، شماره ۳، صفحات ۰-۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023